Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Budde

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipientsP Glander, P Hambach, K P Braun, et al.
Der Urologe. Ausg. A|October 14, 2015
[Immunosuppression and its use in kidney transplantation]A Paliege, J Bamoulid, F Bachmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patientsK Budde, S Bauer, P Hambach, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysisS Morgera, H H Neumayer, L Fritsche, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Cyclosporin C2hour monitoring after renal transplantationG Einecke, I Mai, L Fritsche, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2001
Pharmacodynamic monitoring of mycophenolate mofetilK Budde, P Glander, S Bauer, et al.
Acta Physiologica (Oxford, England)|February 5, 2013
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applicationsE Singer, L Markó, N Paragas, et al.
Transplantation Proceedings|September 2, 1998
Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft functionL Fritsche, H Sperschneider, K Budde, et al.
Case Reports in Dermatology|December 22, 2010
De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based ImmunosuppressionF Friedersdorff, M Giessing, C Roller, et al.
Transplantation Proceedings|December 26, 2001
Steroid withdrawal in long-term cyclosporine A treated patients using mycophenolate mofetil: a prospective randomized pilot studyK Budde, L Fritsche, S Geissler, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipientsP Glander, P Hambach, K P Braun, et al.
Der Urologe. Ausg. A|October 14, 2015
[Immunosuppression and its use in kidney transplantation]A Paliege, J Bamoulid, F Bachmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patientsK Budde, S Bauer, P Hambach, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysisS Morgera, H H Neumayer, L Fritsche, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Cyclosporin C2hour monitoring after renal transplantationG Einecke, I Mai, L Fritsche, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2001
Pharmacodynamic monitoring of mycophenolate mofetilK Budde, P Glander, S Bauer, et al.
Acta Physiologica (Oxford, England)|February 5, 2013
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applicationsE Singer, L Markó, N Paragas, et al.
Transplantation Proceedings|September 2, 1998
Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft functionL Fritsche, H Sperschneider, K Budde, et al.
Case Reports in Dermatology|December 22, 2010
De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based ImmunosuppressionF Friedersdorff, M Giessing, C Roller, et al.
Transplantation Proceedings|December 26, 2001
Steroid withdrawal in long-term cyclosporine A treated patients using mycophenolate mofetil: a prospective randomized pilot studyK Budde, L Fritsche, S Geissler, et al.
Pageof 16